Company intelligence / Profile preview

IrisVision

Pleasanton, California, United Statesirisvision.com ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

IrisVision has developed and commercialized FDA Class I medical devices that use augmented reality and virtual reality technologies to help people with low vision regain functional sight. Their products are in use by thousands of patients globally, providing improved quality of life for individuals with various ocular disorders. The company collaborates with leading academic institutions such as Johns Hopkins University and has received grants from the National Eye Institute.

Therapeutic areas: Ophthalmology
Modalities: DeviceNon-pharmacological therapy (wearable assistive device)
Industry: Assistive Medical Devices

Partnerships

Samsung Electronics AmericaJohns Hopkins University

Beyond the preview

Go deeper on IrisVision.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IrisVision.

Explore the full profile